FDA Clears TriClip for Tricuspid Regurgitation
The FDA has approved Abbott's TriClip Transcatheter Edge-to-Edge Repair system for repairing severe tricuspid regurgitation. The approval was based on positive results from the TRILUMINATE trial, showing significant improvement in…
From Persecution To Patron Saints The Remarkable Stories Of Medical Icons
L.D. George Angus's latest book, Unveiling the Legends, celebrates medical visionaries and their revolutionary contributions. This book takes readers on a journey through the lives and work of medical pioneers…
Advancing therapy with iGlarLixi safe and effective for diabetes treatment irrespective of SGLT2 inhibitors use: Study
A study found that using iGlarLixi therapy is safe and effective for treating diabetes, regardless of whether or not patients are also taking SGLT2 inhibitors. This combination therapy does not…
Providence Spins Out New Patient Engagement Startup With $20M in Funding
Providence's Digital Innovation Group has spun out a new tech startup called Praia Health, focused on personalizing healthcare journeys for patients. The platform, backed by a $20 million funding round,…
Medically, you might be interested in…
Dr. Ray O'Connor compiles and writes about the latest clinical studies, focusing on their practical implications. Studies discussed include the effectiveness of dancing for weight loss, the health benefits of…
Can a Vibrating Ingestible Device Help Combat the Modern Obesity Crisis?
The obesity epidemic is a global issue with significant health implications. Innovative solutions like the vibrating ingestible device offer hope for non-invasive weight management by targeting stomach receptors to induce…
Eko Health’s AI-enabled cardiac tool receives FDA clearance
Digital health startup Eko Health has received FDA clearance for its AI-enabled Eko Low Ejection Fraction Tool (ELEFT) that helps detect low ejection fraction, a sign of heart failure, in…
Track Opioid Settlement Payouts — To the Cent — In Your Community
State and local governments are receiving billions of dollars in settlements from companies involved in the opioid crisis. KFF Health News has been tracking how this money is being used.…
Intra-molecular compound advanced as potential disease-modifying therapy for ALS
A Cincinnati-based life sciences company, Asha Therapeutics, announced the advancement of its development candidate, ASHA-624, as a potential disease modifying therapy for amyotrophic lateral sclerosis (ALS). ASHA-624 is an intra-molecular…
STAT+: Roivant CEO: New deals could ‘materialize later this year’
Roivant Sciences is facing questions about whether its business model can survive its recent successes. The company's drug brepocitinib showed positive results in a study for non-infectious uveitis, while also…